TCI Wealth Advisors’s Medicines Co MDCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-50
Closed -$3K 1755
2019
Q3
$3K Hold
50
﹤0.01% 1016
2019
Q2
$2K Hold
50
﹤0.01% 1113
2019
Q1
$1K Hold
50
﹤0.01% 1380
2018
Q4
$1K Buy
+50
New +$1.16K ﹤0.01% 1396
2018
Q2
Sell
-21
Closed -$1K 1664
2018
Q1
$1K Buy
+21
New +$656 ﹤0.01% 1306
2017
Q4
Sell
-50
Closed -$2K 1460
2017
Q3
$2K Sell
50
-12
-19% -$442 ﹤0.01% 1031
2017
Q2
$2K Hold
62
﹤0.01% 1057
2017
Q1
$3K Buy
62
+12
+24% +$547 ﹤0.01% 884
2016
Q4
$2K Hold
50
﹤0.01% 1083
2016
Q3
$2K Hold
50
﹤0.01% 1038
2016
Q2
$2K Buy
50
+25
+100% +$881 ﹤0.01% 988
2016
Q1
$1K Buy
+25
New +$816 ﹤0.01% 1225

Other funds holding MDCO

TCI Wealth Advisors's MDCO Position: Q4 2019 in Review

TCI Wealth Advisors sold out of Medicines Co (MDCO) in Q4 2019, closing a stake of 50 shares — an estimated $3K sold.

TCI Wealth Advisors first reported a position in MDCO in Q1 2016 and held it in 12 quarters. The position peaked at $3K in Q3 2019. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

  • TCI Wealth Advisors reported no remaining Medicines Co position as of Q4 2019 after selling out during the quarter.
  • TCI Wealth Advisors sold 50 Medicines Co shares in Q4 2019, an estimated $3K.
  • TCI Wealth Advisors first reported a position in Medicines Co in Q1 2016 and held it in 12 quarters.
  • TCI Wealth Advisors's Medicines Co position peaked at $3K in Q3 2019.
  • 284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on TCI Wealth Advisors's 13F filing for Q4 2019, filed 27 Jan 2020.